Marta Calvo-Imirizaldu1, Verónica Aramendia-Vidaurreta1,2, Marta Vidorreta3, Reyes García-Eulate1,2, Pablo Domingez Echeverri1,2, Josef Pfeuffer4, Bartolome Bejarano5, Lain Hermes Gonzalez-Quarante5, Antonio Martinez-Simon6, and María Fernández-Seara1,2
1Radiology, Clínica Universidad de Navarra, Pamplona, Spain, 2IDISNA, Pamplona, Spain, 3Siemens Healthcare, Madrid, Spain, 4Application Development, Siemens Healthcare, Erlangen, Germany, 5Neurosurgery, Clínica Universidad de Navarra, Pamplona, Spain, 6Anesthesia and Intensive Care, Clínica Universidad de Navarra, Pamplona, Spain
Synopsis
ASL has shown potential to depict residual
tumor compared to anatomical imaging in previous intraoperative MRI (iMRI)
study performed at 1.5T. However, the technique has not been evaluated at
higher field, where field inhomogeneities could compromise the labeling
efficiency.
We aimed to assess feasibility and utility
of iMRI-ASL at 3T. To that end, a PCASL sequence was evaluated in 10 patients.
In one patient ASL depicted an additional high CBF focus indicating
neovascularization (known to correlate with higher grade component) that wasn’t
depicted in the anatomical images, favoring the use of ASL in the iMRI
setting to achieve maximal resection.
INTRODUCTION
The standard of care for brain tumors,
primary or metastatic, dictates maximum safe resection, which is known to
improve patients’ progression free survival and quality of life1.
The technically improved neurosurgical treatment of brain tumors yields
higher rates of complete resection, improving patients’ outcomes. Resection
control can be achieved in real time with intraoperative magnetic resonance
imaging (iMRI). Available iMRI units up to 3T field strength can provide high
quality imaging with optimal spatial and temporal resolution comparable to
diagnostic preoperative MRI procedures, allowing the implementation of advanced
imaging protocols2. Among the techniques that can be implemented is
arterial spin labeling (ASL), a perfusion technique that measures cerebral
blood flow (CBF) noninvasively without the use of intravenous contrast agents. ASL
provides absolute CBF measurements, of interest in the characterization of
tumoral vascularization, which is related to higher grade3.
In a previous study iMRI-ASL was performed at 1.5T field strength, showing clinical potential to depict
residual tumor compared to anatomical imaging4,5. However, the technique has not been evaluated at higher field, where
issues related to magnetic field inhomogeneities are exacerbated and could reduce
the labeling efficiency, compromising quality.
This study aimed to evaluate the feasibility, image quality and
potential to depict residual tumor of a pseudo-continuous ASL (PCASL) sequence
in the iMRI setting for resection control in patients undergoing brain tumor
surgery.METHODS
Study was approved by the ethics
committee. Written informed consent was obtained from all subjects before MRI
examination.
Inclusion criteria: patients with brain tumoral
lesions undergoing resection surgery with iMRI-monitorization for resection
control purposes, prospectively recruited. Ten patients met the inclusion criteria.
Prior to surgery, patients underwent a pre-operative
MRI study that included ASL.
iMRI setting
The iMRI study was performed in a 3T MRI scanner
(MAGNETOM Skyra, Siemens Healthcare, Erlangen, Germany) using two flexible-
coils. This equipment is located within the surgical area with
direct access to the operating room, with MR-compatible devices. Patients were
transferred to the MRI suite when the neurosurgeon judged the resection to be
complete or maximally safe.
iMRI protocol
The conventional protocol included precontrast 3D
T1-weighted anatomical images (MPRAGE), diffusion images and postcontrast T1-MPRAGE.
A prototype 3D-PCASL sequence6 with a 3D-GRASE
readout module, long labeling time (LT) of 3000 ms and post labeling delay (PLD)
of 2000 ms was added to the protocol before the injection of exogenous
contrast. Acquisition parameters of 3D-PCASL are presented
in Figure 1.
CBF maps were computed using the single compartment
model7.
Image quality
Three independent observers assessed image
quality of the resultant ASL-CBF maps using a 4-point scale (4, good; 1,
uninterpretable) assisted by example images8. Scores 3-4 were
considered of diagnostic quality (Figure 2).
Interobserver agreement was assessed with Fleiss kappa
statistics. In cases of disagreement, consensus was reached a posteriori.
Resection control
The datasets considered of diagnostic
quality were evaluated by the same observers blindly to assess the presence of
residual tumor by both conventional and ASL sequences, using a 3-point rating
scale (0, no residual tumor; 1, residual tumor; 2, uncertain diagnosis). In
cases of disagreement a consensus was reached. Interobserver agreement was
assessed with Fleiss kappa statistics.
CBF ratio calculation
Intraoperative cerebral blood flow ratio
(CBFratio) calculated by dividing the CBF measured in the surgical cavity
margins or regions of suspected residual tumor by the CBF of the homologous
contralateral hemisphere, was compared to preoperative ASL CBFratio (Wilcoxon’s
rank-sum test).RESULTS AND DISCUSSION
Ten patients met
the inclusion criteria (seven male and three female: 50.2±17 years
[mean±standard deviation], range: 11-76 years).
Image quality
Agreement in
image quality assessment was moderate (Fleiss κ=0.60). In the subsequent
consensus evaluation, diagnostic image quality was observed in 7/10 of the CBF
maps. Among the other 3 cases, two CBF maps were scored as 2 (angiogram-like)
and one was scored as 1 (uninterpretable).
Resection
control
Among the 7
patients with CBF maps of diagnostic quality, the iMRI evaluation with
conventional sequences assessed complete resection in four patients, where ASL
also determined complete removal.
Three patients
had residual tumor assessed with the conventional techniques (1 enhancing
tumor; 2 non-enhancing lesion). ASL showed an additional focus suspicious of
residual tumor in one patient (Figure 3) that
was confirmed in the follow-up.
An advantage of
perfusion techniques is that they are not influenced by the surgically induced
blood-brain barrier breakdown that appears as a lineal enhancement in the
surgical margins, that can interfere in the evaluation of residual tumor with
the conventional techniques9. Our results are consistent with
previous literature evaluating residual component using intraoperative ASL at 1.5T4,5.
Interobserver
variability was similar for conventional sequences (to what radiologists are
used) (Fleiss κ=0.80), and ASL-maps (Fleiss κ=0.79), highlighting the importance
of providing example images/training.
CBF ratio
No significant
differences were found between pre and intraoperative CBFratios (1.51±1.19 and 1.31±0.61,
[mean±standard deviation] respectively, p=1.00) in the three patients with
residual tumor, as expected.
CONCLUSION
ASL is a feasible
technique during iMRI at 3T and is useful for the intraoperative assessment of
residual tumor, providing additional information to the conventional sequences.
This technique can facilitate more aggressive management of highly
hyperperfused residual component, potentially leading to associated survival
benefits.Acknowledgements
Funding: Spanish
Ministry of Science and Innovation (grant: PI18/00084).References
1. Lacroix M, Abi-Said D, Fourney DR,
Gokaslan ZL, Shi W, DeMonte F, Lang FF, McCutcheon IE, Hassenbusch SJ, Holland
E, Hess K, Michael C, Miller D, Sawaya R. A multivariate analysis of 416
patients with glioblastoma multiforme: prognosis, extent of resection, and
survival. J Neurosurg. 2001 Aug;95(2):190-8. doi: 10.3171/jns.2001.95.2.0190.
PMID: 11780887.
2. Rogers CM, Jones PS, Weinberg JS.
Intraoperative MRI for Brain Tumors. J Neurooncol. 2021 Feb;151(3):479-490.
doi: 10.1007/s11060-020-03667-6. Epub 2021 Feb 21. PMID: 33611714.
3. Soldozy S, Galindo J, Snyder H, Ali Y,
Norat P, Yağmurlu K, et al. Clinical utility of arterial spin labeling imaging
in disorders of the nervous system. Neurosurg Focus. 2019;47(6):1–10.
4. Lindner T, Ahmeti H, Lübbing I, Helle M,
Jansen O, Synowitz M, Ulmer S. Intraoperative resection control using arterial
spin labeling - Proof of concept, reproducibility of data and initial results.
Neuroimage Clin. 2017 Apr 25;15:136-142. doi: 10.1016/j.nicl.2017.04.021. PMID:
28507896; PMCID: PMC5423346.
5. Lindner T, Ahmeti H, Juhasz J, Helle M,
Jansen O, Synowitz M, Ulmer S. A comparison of arterial spin labeling and
dynamic susceptibility perfusion imaging for resection control in glioblastoma
surgery. Oncotarget. 2018 Apr
6;9(26):18570-18577. doi: 10.18632/oncotarget.24970. PMID: 29719627; PMCID:
PMC5915094.
6. Vidorreta M, Wang Z,
Rodríguez I, Pastor MA, Detre JA, Fernández-Seara MA. Comparison
of 2D and 3D single-shot ASL perfusion fMRI sequences. Neuroimage. 2013 Feb
1;66:662-71. doi: 10.1016/j.neuroimage.2012.10.087. Epub 2012 Nov 7. PMID:
23142069; PMCID: PMC3587033.
7. Alsop DC, Detre JA, Golay X, Günther M,
Hendrikse J, Hernandez-Garcia L, Lu H, MacIntosh BJ, Parkes LM, Smits M, van
Osch MJ, Wang DJ, Wong EC, Zaharchuk G. Recommended implementation of arterial
spin-labeled perfusion MRI for clinical applications: A consensus of the ISMRM
perfusion study group and the European consortium for ASL in dementia. Magn
Reson Med. 2015 Jan;73(1):102-16. doi: 10.1002/mrm.25197. Epub 2014 Apr 8.
PMID: 24715426; PMCID: PMC4190138.
8. Ferro DA, Mutsaerts HJ, Hilal S, Kuijf
HJ, Petersen ET, Petr J, van Veluw SJ, Venketasubramanian N, Yeow TB, Biessels
GJ, Chen C. Cortical microinfarcts in memory clinic patients are associated
with reduced cerebral perfusion. J Cereb Blood Flow Metab. 2020
Sep;40(9):1869-1878. doi: 10.1177/0271678X19877403. Epub 2019 Sep 26. PMID:
31558107; PMCID: PMC7430096.
9. Ulmer S, Helle M, Jansen O, Mehdorn HM, Nabavi
A. Intraoperative dynamic susceptibility contrast weighted magnetic resonance
imaging (iDSC-MRI) - Technical considerations and feasibility. Neuroimage. 2009
Mar 1;45(1):38-43. doi: 10.1016/j.neuroimage.2008.11.021. Epub 2008 Dec 6.
PMID: 19100843.